We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Astellas Pursues Pediatric Exclusivity to Extend Flomax Patent
Astellas Pursues Pediatric Exclusivity to Extend Flomax Patent
March 6, 2007
Astellas Pharma is moving to extend patent protection for its enlarged-prostate treatment Flomax, a blockbuster drug that generated more than $1 billion in sales last year, the company said.